Food and Drug Administration appealing ruling over GM salmon potential environmental consequences

editorial staff

US agency was ordered to “go back and complete the analysis,” last November.

Reuters reports that the U.S. Food and Drug Administration is appealing a lower court ruling over genetically engineered salmon.

In November, a federal court judge ruled that the U.S. Food and Drug Administration did not analyse enough the impact of genetically engineered salmon if they escaped in the wild.

U.S. District Court Judge Vince Chhabria in San Francisco was focused on AquaBounty’s genetically engineered-fast growing AquAdvantage salmon. He said that “with every new facility built, the possibility of exposure grows. Understanding the harm that could result from that exposure—and having an explanation of it on record—will only become more important”.

The biotech company is working on its first harvest of GM salmon, which are being raised in a land-based RAS facility in Albany, Indiana.

Back in November, CEO Sylvia A. Wulf told SalmonBusiness that the above decision “will not have an impact on our ongoing operations on Prince Edward Island, Canada, to produce eggs or in the raising and selling of AquAdvantage salmon from our farm in Indiana”.


Related Articles